吸入甲氧氟烷用于急诊科创伤相关疼痛管理:一项随机、双盲、安慰剂对照试验(PenASAP研究)
本研究为在8个急诊科开展的随机、双盲、安慰剂对照试验,纳入入院时疼痛评分≥4(11点NRS)的成人创伤患者,比较吸入甲氧氟烷联合标准治疗(m-SoC)与安慰剂联合标准治疗(p-SoC)的镇痛效果。共分析351例(m-SoC组178例,p-SoC组173例),首次吸入前中位疼痛66 mm,75%为重度疼痛(NRS 6-10)。m-SoC组疼痛缓解至VAS≤30 mm的中位时间为35分钟(95%CI 28-62),p-SoC组未达到(92-未达到),HR 1.93(95%CI 1.43-2.60),P<0.001;重度疼痛亚组HR 2.5(95%CI 1.7-3.7)。m-SoC组阿片类药物升级比例更低(8% vs 17%,P=0.02),多数不良事件为轻度(111/147)。
要点
- 分诊护士启动吸入甲氧氟烷联合标准治疗,使急诊创伤中重度疼痛患者疼痛缓解至VAS≤30 mm的中位时间缩短至35分钟(95%CI 28-62),安慰剂组未达到(HR 1.93,95%CI 1.43-2.60,P<0.001)。
- 重度疼痛亚组(NRS 6-10)获益更明显,HR 2.5(95%CI 1.7-3.7)。
- 甲氧氟烷组阿片类药物升级比例更低:弱或强阿片类升级8% vs 17%(P=0.02)。
- 多数不良事件为轻度(111/147),但原文未报告具体不良事件类型。
适用人群与场景
- 成人创伤患者,入院时疼痛评分≥4(11点NRS),在8个急诊科就诊。
诊断标准与关键阈值
- 疼痛评分≥4(11点NRS)作为入组阈值。
- 疼痛缓解定义为VAS≤30 mm(100-mm视觉模拟量表)。
处置流程与药物剂量
- 由分诊护士启动,吸入甲氧氟烷(1或2个吸入器)联合标准治疗(m-SoC),与安慰剂联合标准治疗(p-SoC)对比。
- 标准治疗包括弱阿片类药物(24例,7%;m-SoC组6% vs p-SoC组8%)、强阿片类药物(4例,1%)以及升级至弱或强阿片类药物(44例,13%;m-SoC组8% vs p-SoC组17%,P=0.02)。
研究设计与关键结果
- 随机、双盲、安慰剂对照试验,在8个急诊科开展,共分析351例患者(m-SoC组178例,p-SoC组173例)。
- 首次吸入前中位疼痛66 mm,75%患者为重度疼痛(NRS 6-10)。
- 主要终点:疼痛缓解至VAS≤30 mm的中位时间,m-SoC组35分钟(95%CI 28-62) vs p-SoC组未达到(92-未达到),HR 1.93(95%CI 1.43-2.60),P<0.001。
- 重度疼痛亚组:HR 2.5(95%CI 1.7-3.7)。
- 阿片类药物使用:弱阿片类24例(7%;m-SoC组6% vs p-SoC组8%),强阿片类4例(1%),升级至弱或强阿片类44例(13%;m-SoC组8% vs p-SoC组17%,P=0.02)。
- 不良事件:多数为轻度(111/147)。
证据类型、等级与局限
- 证据类型:随机、双盲、安慰剂对照试验。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,由分诊护士启动吸入甲氧氟烷作为多模式镇痛的一部分,可有效缓解创伤患者的疼痛,尤其在重度疼痛亚组中效果更明显。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Oligo-analgesia is common in the emergency department (ED). This study aimed at reporting, when initiated by triage nurse, the superior efficacy of inhaled methoxyflurane plus standard of care (m-SoC) analgesia versus placebo plus SoC (p-SoC) for moderate-to-severe trauma-related pain in the hospital ED.
METHODS: A randomised, double-blind, placebo-controlled trial was conducted at eight EDs. Adults with pain score ≥4 (11-point numerical rate scale, NRS) at admission were randomised to receive one or two inhalers containing m-SoC or p-SoC. Primary outcome measure was time until pain relief ≤30 mm, assessed on the 100-mm Visual Analogic Scale (VAS).
RESULTS: A total of 351 patients were analysed (178 m-SoC; 173 p-SoC). Median pain prior to first inhalation was 66 mm, 75% had severe pain (NRS 6-10). Median time to pain relief was 35 min [95% confidence interval (CI), 28-62] for m-SoC versus not reached in p-SoC (92 - not reached) [hazard ratio), 1.93 (1.43-2.60), P < 0.001]. Pain relief was most pronounced in the severe pain subgroup: hazard ratio, 2.5 (1.7-3.7). As SoC, 24 (7%) patients received weak opioids (6 versus 8%), 4 (1%) strong opioid and 44 (13%) escalated to weak or strong opioids (8 versus 17%, respectively, P = 0.02). Most adverse events were of mild (111/147) intensity.
CONCLUSIONS: In this study, we report that methoxyflurane, initiated at triage nurse as part of a multimodal analgesic approach, is effective in achieving pain relief for trauma patients. This effect was particularly pronounced in the severe pain subgroup.
参考来源
- Ricard-Hibon A, Lecoules N, Savary D, et al. Inhaled methoxyflurane for the management of trauma related pain in patients admitted to hospital emergency departments: a randomised, double-blind placebo-controlled trial (PenASAP study). Eur J Emerg Med. 2020. PMID: 32282467. doi:10.1097/MEJ.0000000000000686
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。